Changes in Serum Osteocalcin are Not Associated with Changes in Glucose or Insulin for Osteoporotic Patients Treated with Bisphosphonate

BACKGROUND: Bisphosphonate is used in osteoporosis treatment to repress osteoclast activity, which then decreases levels of osteocalcin (OC). OC, a protein secreted by osteoblasts and released from the bone matrix during osteoclastic bone resorption, has been found to control blood glucose levels by...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Hong, Seong-hun, Koo, Ja-won, Hwang, Jin Kyung, Hwang, You-Cheol, Jeong, In-Kyung, Ahn, Kyu Jeung, Chung, Ho-Yeon, Kim, Deog-Yoon
Format: Artigo
Sprog:Inglês
Udgivet: The Korean Society for Bone and Mineral Research 2013
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3780832/
https://ncbi.nlm.nih.gov/pubmed/24524054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11005/jbm.2013.20.1.37
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker